PARP1 and breast carcinoma: In a study using a bladder cancer case-control series (752 cases and 704 controls) as well as a breast cancer case-control series (257 cases and 512 controls) from UK, Mark et al. 49 found that PARP1 rs8679 was associated with increased bladder cancer and breast cancer risk.